Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Tracking John Paulson's Paulson & Company Portfolio - Q4 2017 Update

2018-02-20 seekingalpha
This article is part of a series that provides an ongoing analysis of the changes made to John Paulson’s US stock portfolio on a quarterly basis. It is based on Paulson’s regulatory 13F Form filed on 02/14/2018. Please visit our Tracking John Paulson’s Paulson & Company Portfolio series to get an idea of his investment philosophy and our previous update for the fund’s moves during Q3 2017. (1077-8)

OxyContin maker stops promoting opioids, cuts sales staff

2018-02-11 cnbc
OxyContin maker Purdue Pharma LP said on Saturday that it has cut its sales force in half and will stop promoting opioids to physicians, following widespread criticism of the ways that drugmakers market addictive painkillers. (22-0)

UPDATE 2-OxyContin maker stops promoting opioids, cuts sales staff

2018-02-10 reuters
(Reuters) - OxyContin maker Purdue Pharma LP said on Saturday that it has cut its sales force in half and will stop promoting opioids to physicians, following widespread criticism of the ways that drugmakers market addictive painkillers. (22-0)

ENDP / Endo International plc - Stock Institutional Ownership and Shareholders - Fintel.io

2018-02-08 fintel.io
Endo International plc (NASDAQ:ENDP) has 328 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 213,645,771 shares. Largest shareholders include TPG Group Holdings (SBS) Advisors, Inc., BlackRock Inc., Vanguard Group Inc, Glenview Capital Management, Llc, Dimensional Fund Advisors Lp, State Street Corp, Lmm Llc, Paulson & Co. (70-0)

Your Daily Pharma Scoop: Nabriva Pullback, GW Pharmaceuticals Makes Progress, ContraVir Announces Promising Results

2018-02-07 seekingalpha
Today we will discuss Nabriva Therapeutics (NBRV), which saw a sharp pullback in after-hours trading on Monday. (936-0)

Purdue’s Oxycontin Targeted at Judge’s Opioid Summit - Bloomberg

2018-02-02 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (46-0)

Biotech Forum Daily Digest For January 29th

2018-01-29 seekingalpha
Biotech just had one of best weeks in recent memory and we have another acquisition this morning to report. (326-1)

Everything That Could Go Wrong for This Drugmaker Did - Bloomberg

2018-01-26 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (321-5)

New York City sues drug companies over opioid epidemic

2018-01-23 cnbc
New York City on Tuesday sued eight companies that make or distribute prescription opioids, blaming them for a deadly epidemic afflicting the most populous U.S. city. (175-0)

UPDATE 1-New York City sues drug companies over opioid epidemic

2018-01-23 reuters
NEW YORK, Jan 23 (Reuters) - New York City on Tuesday sued eight companies that make or distribute prescription opioids, blaming them for a deadly epidemic afflicting the most populous U.S. city. (272-0)

Delaware sues opioid manufacturers, distributors over epidemic

2018-01-19 reuters
(Reuters) - Delaware on Friday became the latest state to file a lawsuit accusing corporations of helping fuel the national opioid epidemic, suing a wide range of companies involved in making, distributing and selling prescription painkillers. (207-0)

Generic-Drug Makers Fall as Justice Department Threatens to Sue - Bloomberg

2018-01-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. (151-0)

UPDATE 1-U.S. hospital systems team up to launch generic drugmaker

2018-01-18 reuters
NEW YORK, Jan 18 (Reuters) - A group of four hospital systems plans to launch a not-for-profit generic drugmaker aimed at combating shortages and high costs of some generic drugs, which they blame on unscrupulous drug companies that hike prices. (218-0)

Endo (ENDP) Loses 35% in a Year: Can It Turn Around in 2018?

2018-01-16 zacks
Shares of Endo International plc (ENDP - Free Report) have tumbled 35.4% over a year against the industry’s gain of 7.1%. (57-0)